Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
54.00
-1.28 (-2.32%)
At close: Jun 18, 2026, 4:00 PM EDT
54.05
+0.05 (0.09%)
After-hours: Jun 18, 2026, 7:58 PM EDT

BMY Revenue

Bristol-Myers Squibb Company had revenue of $11.49B in the quarter ending March 31, 2026, with 2.57% growth. This brings the company's revenue in the last twelve months to $48.48B, up 1.78% year-over-year. In the year 2025, Bristol-Myers Squibb Company had annual revenue of $48.19B, down -0.22%.

Revenue (ttm)
$48.48B
Revenue Growth
+1.78%
P/S Ratio
2.27
Revenue / Employee
$1,491,754
Employees
32,500
Market Cap
110.27B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202548.19B-106.00M-0.22%
Dec 31, 202448.30B3.29B7.32%
Dec 31, 202345.01B-1.15B-2.50%
Dec 31, 202246.16B-226.00M-0.49%
Dec 31, 202146.39B3.87B9.09%
Dec 31, 202042.52B16.37B62.62%
Dec 31, 201926.15B3.58B15.89%
Dec 31, 201822.56B1.79B8.59%
Dec 31, 201720.78B1.35B6.94%
Dec 31, 201619.43B2.87B17.31%
Dec 31, 201516.56B681.00M4.29%
Dec 31, 201415.88B-506.00M-3.09%
Dec 31, 201316.39B-1.24B-7.01%
Dec 31, 201217.62B-3.62B-17.05%
Dec 31, 201121.24B1.76B9.03%
Dec 31, 201019.48B676.00M3.59%
Dec 31, 200918.81B1.09B6.17%
Dec 31, 200817.72B2.10B13.43%
Dec 31, 200715.62B-591.00M-3.65%
Dec 31, 200616.21B-2.40B-12.88%
Dec 31, 200518.61B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Merck & Co.65.77B
Pfizer63.32B
AbbVie62.82B
AstraZeneca60.44B
Novartis AG56.58B
Sanofi54.60B
Novo Nordisk50.57B
GSK plc43.29B
Revenue Rankings